Ashwin Pharmaceuticals Private Limited
About Ashwin Pharmaceuticals Private Limited
Data last updated:
Ashwin Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2013.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2013PTC259819.
The company had an authorised share capital of ₹1.4 Cr and a paid-up capital of ₹94 Lakh. It was led by directors Aditya Kumar Bhandari and Pranav Srivastava.
Its last annual general meeting (AGM) was held on 27 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
Company details
Contact details
Ashwin Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ashwin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ashwin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Ashwin Pharmaceuticals Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ashwin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ashwin Pharmaceuticals Private Limited
Ashwin Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Kumar Bhandari Also directs: Rockland Hotels Limited, Rockland Hotels Rudrapur Private Limited, Lipi Finstock Limited and 1 more | Director | 12 Sep 2018 | 8 Years 1 Months | As last reported |
| Pranav Srivastava Also directs: Rockland Finstock Limited | Director | 28 Apr 2016 | 10 Years 6 Months | As last reported |
Auditor
Ashwin Pharmaceuticals Private Limited is audited by SANGITA GUPTA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANGITA GUPTA & ASSOCIATES | FY 2018 | 023808N |
Shareholding
The shareholding of Ashwin Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ashwin Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ashwin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ashwin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ashwin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ashwin Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Jhantu Mandal ceased to be Director on 14 Sep 2018.
Frequently asked questions
Ashwin Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ashwin Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2013 and is registered under CIN U51101DL2013PTC259819. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ashwin Pharmaceuticals was incorporated on 01 November 2013. It is registered with the Registrar of Companies, Delhi.
Ashwin Pharmaceuticals had 2 directors:
- Aditya Kumar Bhandari - Director
- Pranav Srivastava - Director
The CIN (Corporate Identification Number) of Ashwin Pharmaceuticals is U51101DL2013PTC259819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ashwin Pharmaceuticals is at C – 30 Panchsheel Enclave, New Delhi, Delhi, India – 110017.
The latest financial statements of Ashwin Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 27 September 2021. Year-wise statements from 2015 are in the company report.
Ashwin Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Jhantu Mandal ceased to be Director on 14 Sep 2018. Aditya Kumar Bhandari was appointed as Director on 12 Sep 2018. Pranav Srivastava ceased to be Additional Director on 30 Sep 2016. Ashwin Pharmaceuticals has 5 board changes on record in total.
The compliance status of Ashwin Pharmaceuticals is compliant as of 03 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
